- Philips IntelliSpace Cognition provides U.S. healthcare professionals with a powerful aid for assessing cognitive impairments due to neurological conditions.
- Philips has invested in collecting insights from both neurologists and neuropsychologists in order to design IntelliSpace Cognition in an iterative manner and ensure it fits into the majority of existing workflows.
- IntelliSpace Cognition will initially be commercially available only in the U.S.
Philips, a global leader in
Read More
neurological conditions
Accenture, Biogen, 1QBit Launch Quantum Computing App to Accelerate Drug Discovery
Accenture and Biogen have developed a first-of-a-kind quantum-enabled molecular comparison app designed to speed up drug discovery for complex neurological conditions such as MS, Alzheimer’s, Parkinson’s and Lou Gehrig’s disease. Researchers at Accenture Labs collaborated with 1QBit to create the new application which enhances Biogen’s existing molecule comparison method with quantum capabilities.Molecular comparison is a crucial part of early-phase drug design and discovery, and involves
Read More
